'Sakigake' Treatment Gives Enhertu Rapid Japan OK For Gastric Cancer
Zejula, Tecentriq Combo Also Cleared
Japan approves a batch of new products and indications, including Daiichi Sankyo's Enhertu in a high-need indication after a rapid review and Takeda's Zejula, which will be made available to selected patients before its reimbursement listing.
